![Julian Adams](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julian Adams
Président chez
ELICIO THERAPEUTICS, INC.
Fortune : - $ au 31/05/2026
Profil
Julian Adams currently works at Stand Up To Cancer, as President & Chief Executive Officer from 2023, Elicio Therapeutics, Inc., as Independent Chairman from 2017, and Princess Margaret Cancer Foundation, as Director from 2014.
Dr. Adams also formerly worked at Elicio Therapeutics, Inc. (United States), as Chairman from 2017 to 2023, Rein Therapeutics, Inc., as Director from 2011 to 2013, ProScript, Inc., as Director, Executive VP-Research & Development, Boehringer Ingelheim Corp., as Director-Medicinal Chemistry, Predix Pharmaceuticals Holdings, Inc., as Director, CureTech Ltd., as Director, Warp Drive Bio, Inc., as Director, Pieris Pharmaceuticals, Inc., as Independent Director from 2016 to 2018, BioNTech US, Inc., as Independent Director from 2017 to 2018, Gamida Cell Ltd., as Independent Director from 2022 to 2024, Merck & Co., Inc., as Medicinal Chemist from 1982 to 1987, Millennium Pharmaceuticals, Inc., as Senior Vice President-Drug Discovery & Development from 1999 to 2003, LeukoSite, Inc., as Senior Vice President-Research & Development in 1999, Clal Biotechnology Industries Ltd., as President & Chief Science Officer in 2017, Infinity Pharmaceuticals, Inc., as President-Research & Development from 2011 to 2017, Limulus Management Co. LLC, as Advisor, Clal Biotechnology Industries Ltd. (Venture Capital), as President & Chief Science Officer, and Infinity Discovery, Inc., as President in 2006.
Dr. Adams received his undergraduate degree in 1977 from McGill University and doctorate degree in 1981 from Massachusetts Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Julian Adams
| Sociétés | Poste | Début |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Président | 01/01/2017 |
Princess Margaret Cancer Foundation
 Princess Margaret Cancer Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Directeur/Membre du Conseil | 01/11/2014 |
Stand Up To Cancer
 Stand Up To Cancer Miscellaneous Commercial ServicesCommercial Services Provides charitable program services | Directeur Général | 01/07/2023 |
Anciens postes connus de Julian Adams
| Sociétés | Poste | Fin |
|---|---|---|
| GAMIDA CELL LTD. | Directeur Général | 19/09/2022 |
Elicio Therapeutics, Inc. (United States)
 Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Président | 01/06/2023 |
| NEON THERAPEUTICS, INC. | Directeur/Membre du Conseil | 28/08/2018 |
| PIERIS PHARMACEUTICALS | Directeur/Membre du Conseil | 24/07/2018 |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | President | 01/11/2017 |
Formation de Julian Adams
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
23
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 23 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer and inflammatory diseases | Health Technology |
Rein Therapeutics, Inc.
 Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
Elicio Therapeutics, Inc. (United States)
Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Health Technology |
Clal Biotechnology Industries Ltd.
 Clal Biotechnology Industries Ltd. Financial ConglomeratesFinance Provides investment and support services for life science research companies | Finance |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProScript, Inc.
 ProScript, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer treatments | Health Technology |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Limulus Management Co. LLC
 Limulus Management Co. LLC Investment ManagersFinance Limulus Management Co LLC invests in healthcare/life science companies located in the US. The firm focuses on companies with intellectual property positions and growth potential. It targets companies operating in the fields of biopharmaceutical technology and life sciences information. It provides financing for early stage capital requirements with an investment size ranging from $4 to $8 million. | Finance |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Health Technology |
Predix Pharmaceuticals Holdings, Inc.
 Predix Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Discovers and developes novel, highly selective, small-molecule drugs | Health Technology |
Gamida Cell Ltd.
 Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
CureTech Ltd.
 CureTech Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Clal Biotechnology Industries Ltd. (Venture Capital)
 Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries invests in companies located in Israel. The firm focuses on biotechnology and medical technology. It provides financing for seed and early stage capital requirements. | Finance |
Infinity Discovery, Inc. | |
Stand Up To Cancer
Stand Up To Cancer Miscellaneous Commercial ServicesCommercial Services Provides charitable program services | Commercial Services |
Warp Drive Bio, Inc.
 Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Focuses on proprietary genomic technology to discover drugs of natural origin | Commercial Services |
Princess Margaret Cancer Foundation
Princess Margaret Cancer Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Pieris Pharmaceuticals, Inc.
 Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology | Health Technology |
BioNTech US, Inc.
 BioNTech US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for cancer | Health Technology |
Elicio Therapeutics, Inc.
 Elicio Therapeutics, Inc. BiotechnologyHealth Technology Develops cancer immunotherapies | Health Technology |
